Daily Morning Note – 4 March 2019

WEEKLY MARKET OUTLOOK WEBINAR

Register HERE for MONDAY’s 11.15am webinar.

Archived webinars available.

YOUR PHILLIP SUMMARY

Most or all U.S. tariffs on China are likely to be lifted as part of a trade deal between the world’s two-largest economies now in its final stages, said two people familiar with the discussions. Beijing made clear in a series of recent negotiations with the U.S. that removing the tariffs on $200 billion of Chinese goods from day one was necessary to finalize any deal, said the people, who weren’t authorized to talk publicly about the deliberations. China is offering to lower tariffs on U.S. farm, chemical, auto and other products, the Wall Street Journal reported earlier, citing people familiar.

The inflation outlook is looking dismal for the Bank of Japan as cheaper oil and falling mobile phone charges threaten to push price growth toward zero by mid-summer. The Bloomberg Inflation Barometer, which draws on eight drivers of prices, points to a sharp slowing in the months ahead as lower oil costs feed their way into electricity bills. Over the past eight years the barometer has shown a 0.84 correlation with consumer prices six months into the future. Mobile phone carriers could complicate the BOJ’s quest to revive inflation as they come under political pressure to lower charges further.



RESEARCH REPORT

China Sunsine Chemical Holdings Ltd – Focus on volume growth

Recommendation: BUY, Last Closing Price: S$1.26

Target Price: S$1.55, Analyst: Chen Guangzhi

– Expect 50% and 28% jump in IS and TBBS sales volume in FY19 but ASP to slip.

– The 5.5 SG cents annual dividend represents a 4.3% yield.

– Valuations are still attractive at 6x PE (with 1/3 of the market cap in cash).

EC World REIT – Optimistic about the outlook

Recommendation: BUY (Maintained), Last Closing Price: S$0.760

Target Price: $0.85 (previous TP $0.82) Analyst: Phillip Research Team

– NPI and DPU were in line with our forecast. 5.3% and 5.6% YoY boost in gross revenue and
NPI, respectively, driven by the acquisitions of Wuhan Meiluote in 2Q17.

– Wuhan asset performing well after acquisition; slow rap-up of occupancy at Beigang.

– Early renewal of master lease on favourable terms, pending shareholder vote at an EGM to
be convened.

– Maintain Buy with higher TP of S$0.85 (prev. S$0.82).

Sheng Siong Group – New stores will support growth

Recommendation: ACCUMULATE (Maintained), Last Closing Price: S$1.08

Target Price: $1.30 (previous TP $1.13) Analyst: Paul Chew

– 4Q18 revenue and earnings met our expectations. Headline PATMI in 4Q18 was hurt by a
S$2.3mn decline in government grants.

– Gross margin is stellar but some revenue drag from contraction in same-store sales

– Expect strong revenue momentum following the 23% jump in retail space in FY18

– We have kept our forecast unchanged. As we roll-over our target price to FY19e valuation, we
raised our target price to S$1.30 (previously S$1.13) or 25x PE. Maintain ACCUMULATE.

Singapore Banking Monthly – Mortgage growth at a 17-year low

Recommendation: Overweight (Maintained); Analyst: Tin Min Ying

– January’s domestic loan growth remained flat at 3.16% YoY, held up by building and
construction loan while mortgage growth was the slowest in seventeen years.

– January’s domestic deposits rose 4.8% YoY, boosted by fixed deposit growth of 15.1% YoY,
the fastest in eleven years.

– February’s 3-month SIBOR is still rising. It is now 1.953%, surpassing last month’s 11 yearhigh.

– Hong Kong’s January loan growth remained flat at 3.1% YoY.

– Maintain OVERWEIGHT for the Singapore Banking Sector.

BREAKING NEWS

First Sponsor plans to buy Concord Focus Development, which owns three land parcels in China’s Guangdong province totalling 36,405 square metres (sq m), for 738 million yuan (S$148.9 million).First Sponsor said that the property has land use rights with expiry dates of Jan 31, 2088 for residential use and Jan 31, 2058 for commercial use.

Hyflux has taken a S$916 million impairment for the nine months ended Sept 30, to adjust for a fall in carrying value of the Tuaspring water and power plant and other write-downs. This figure was released on Saturday, after Hyflux submitted its latest statement of financial position to the High Court.

Indonesia and Australia are set to ink a long-awaited trade deal on Monday, after months of diplomatic tension over Canberra’s contentious plan to move its embassy to Jerusalem. The pact will include improved access for Australian cattle and sheep farmers to Indonesia’s 260 million people, while Australian universities, health providers and miners will also benefit from easier entry to South-east Asia’s biggest economy.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR

Clients of Phillip Securities can keep updated with Country Strategy and Singapore Sector Reports by logging into: www.poems.com.sg > STOCKS > Research

Read the research report(s), available through the link(s) above, for complete information including important disclosures

Important Information

Disclaimer
The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided “as is” without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

 

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com